PPARs

ABT-888 (Veliparib) View larger

ABT-888 (Veliparib)

AOB87114

CAS No:912444-00-9

More details

Molarity Calculation Cart®

HOW TO ORDER

$11.00

$11.00 per mg

Quantity Discount Table - Order More To Get More Price Discount

QuantitymgUnit Price ($/mg or $/Unit)Final Price
1100 $4.95 Total: $495.00
150 $5.72 Total: $286.00
125 $6.71 Total: $167.75
110 $7.92 Total: $79.20
15 $9.35 Total: $46.75

Data sheet

Molecular FormulaC13H18Cl2N4O
Molecular Weight317.21
CAS Numbers912445-05-7
Storage Condition0°C (short term), -20°C (long term), desiccated
SolubilityDMSO
Purity98% by HPLC
SynonymABT888; ABT-888; ABT 888; Veliparib
IUPAC/Chemical Name(R)-2-(2-methylpyrrolidin-2-yl)-1H-benzo[d]imidazole-4-carboxamide
InChl KeyJNAHVYVRKWKWKQ-CYBMUJFWSA-N
InChl CodeInChI=1S/C13H16N4O/c1-13(6-3-7-15-13)12-16-9-5-2-4-8(11(14)18)10(9)17-12/h2,4-5,15H,3,6-7H2,1H3,(H2,14,18)(H,16,17)/t13-/m1/s1
SMILES CodeO=C(C1=C2C(NC([C@]3(C)NCCC3)=N2)=CC=C1)N
References1) Bhute VJ, et al. The Poly (ADP-Ribose) Polymerase Inhibitor Veliparib and Radiation Cause Significant Cell Line Dependent Metabolic Changes in Breast Cancer Cells. Sci Rep. 2016 Nov 4;6:36061. doi: 10.1038/srep36061. PubMed PMID: 27811964; PubMed Central PMCID: PMC5095763.

2) Ramalingam SS, et al., Placebo-Controlled, Phase 2 Study of Veliparib in Combination with Carboplatin and Paclitaxel for Advanced/Metastatic Non-Small Cell Lung Cancer. Clin Cancer Res. 2016 Oct 10. pii: clincanres.3069.2016. [Epub ahead of print] PubMed PMID: 27803064.

More info

A potent and orally active poly(ADP-ribose) polymerase (PARP) inhibitor with Ki at low nM (< 5nM in vitro). It does not inhibit other NAD-binding enzymes.

Customers who bought this product also bought: